Epofolate

DRUG2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Advanced Solid Tumors

Phase 1

A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1)

TerminatedNCT00546247

Bristol-Myers SquibbAdvanced Solid Tumors

Start: 2008-01-31End: 2010-03-31Updated: 2015-10-12

A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2)

TerminatedNCT00550017

Bristol-Myers SquibbAdvanced Solid Tumors

Start: 2007-12-31End: 2010-03-31Updated: 2015-10-12